Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
4DMedical Ltd ( (AU:4DX) ) has provided an announcement.
4DMedical Limited has requested and been granted a trading halt on its ordinary shares on the ASX from the start of trading on 13 January 2026, expected to last until trading resumes on 15 January 2026 or until a further announcement is made. The halt has been sought to allow the company to consider, plan and execute a capital raising, signalling an imminent move to secure additional funding that could support its growth initiatives and operational needs, with the board formally authorising the request and affirming there is no other information required to inform the market at this time.
The most recent analyst rating on (AU:4DX) stock is a Sell with a A$3.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited is an Australian-based medical technology company focused on lung health, with operations in Melbourne and Los Angeles. The company develops and commercialises imaging and analytical solutions for respiratory function, targeting improved diagnosis and management of lung disease in clinical and research settings.
Average Trading Volume: 4,682,062
Technical Sentiment Signal: Buy
Current Market Cap: A$2.47B
See more data about 4DX stock on TipRanks’ Stock Analysis page.